Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

3 terminated/withdrawn out of 9 trials

Success Rate

57.1%

-29.4% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 2

4(50.0%)

N/A

2(25.0%)

Phase 3

1(12.5%)

Phase 1

1(12.5%)

8Total

Phase 2(4)

N/A(2)

Phase 3(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT00863226Phase 3Unknown

Study of the Application of Magnetic Fields for the Treatment of Parkinson's Disease

Role: lead

NCT00779155Phase 2Completed

Study of Magnetic Fields for Treatment of Parkinson's Disease

Role: lead

NCT00862537Completed

Evaluation of Long-term Effect of Resonator Therapy on Parkinson's Disease (PD)

Role: lead

NCT01195389Not ApplicableUnknown

Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease

Role: lead

NCT01262131Phase 2Completed

Evaluation of Magnetic Fields to Treat Fibromyalgia

Role: lead

NCT01312285Phase 2Withdrawn

Low Level Magnetic Fields for the Treatment of Osteoarthritis of the Hip

Role: lead

NCT01313806Not ApplicableWithdrawn

Study of Magnetic Fields to Treat Alzheimer's Disease

Role: lead

NCT00982293Phase 2Terminated

The Application of Extremely Low Level Magnetic Fields as Adjunctive Treatment for Type II Diabetes

Role: lead

NCT00863954Phase 1Completed

Application of Magnetic Fields as Adjunctive Treatment for Type II Diabetes

Role: lead

All 9 trials loaded